HA+ Trademark

Trademark Overview


On Wednesday, September 25, 2024, a trademark application was filed for HA+ with the United States Patent and Trademark Office. The USPTO has given the HA+ trademark a serial number of 98767760. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, October 21, 2025. This trademark is owned by Axogen Corporation. The HA+ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations, composed of a combination of sodium hyaluronate and sodium alginate, for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for us...

Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising natural, non-living material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising synthetic material
ha+

General Information


Serial Number98767760
Word MarkHA+
Filing DateWednesday, September 25, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkHA PLUS
Goods and ServicesImplants comprising living tissue; Implants comprising biological tissue and chemical preparations, composed of a combination of sodium hyaluronate and sodium alginate, for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising biological tissue
Goods and ServicesSurgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising natural, non-living material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising synthetic material

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2024
Primary Code005
First Use Anywhere DateMonday, December 5, 2022
First Use In Commerce DateFriday, May 12, 2023

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2024
Primary Code010
First Use Anywhere DateMonday, December 5, 2022
First Use In Commerce DateFriday, May 12, 2023

Trademark Owner History


Party NameAxogen Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33602

Trademark Events


Event DateEvent Description
Wednesday, September 25, 2024NEW APPLICATION ENTERED
Monday, December 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 31, 2025ASSIGNED TO EXAMINER
Monday, March 31, 2025NON-FINAL ACTION WRITTEN
Monday, March 31, 2025NON-FINAL ACTION E-MAILED
Monday, March 31, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 20, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, June 20, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 21, 2025SUSPENSION LETTER WRITTEN
Tuesday, October 21, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, October 21, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED